COVID-Datathon: Biomarker identification for COVID-19 severity based on BALF scRNA-seq data

10/11/2021
by   Seyednami Niyakan, et al.
0

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emergence began in late 2019 and has since spread rapidly worldwide. The characteristics of respiratory immune response to this emerging virus is not clear. Recently, Single-cell RNA sequencing (scRNA-seq) transcriptome profiling of Bronchoalveolar lavage fluid (BALF) cells has been done to elucidate the potential mechanisms underlying in COVID-19. With the aim of better utilizing this atlas of BALF cells in response to the virus, here we propose a bioinformatics pipeline to identify candidate biomarkers of COVID-19 severity, which may help characterize BALF cells to have better mechanistic understanding of SARS-CoV-2 infection. The proposed pipeline is implemented in R and is available at https://github.com/namini94/scBALF_Hackathon.

READ FULL TEXT

page 1

page 2

page 3

page 4

research
12/25/2020

COVIDX: Computer-aided diagnosis of Covid-19 and its severity prediction with raw digital chest X-ray images

Coronavirus disease (COVID-19) is a contagious infection caused by sever...
research
07/05/2021

Identification and validation of Triamcinolone and Gallopamil as treatments for early COVID-19 via an in silico repurposing pipeline

SARS-CoV-2, the causative virus of COVID-19 continues to cause an ongoin...
research
03/28/2020

Knowledge synthesis from 100 million biomedical documents augments the deep expression profiling of coronavirus receptors

The COVID-19 pandemic demands assimilation of all available biomedical k...
research
10/27/2020

A Comprehensive Dictionary and Term Variation Analysis for COVID-19 and SARS-CoV-2

The number of unique terms in the scientific literature used to refer to...
research
08/22/2020

COVID-19 Pandemic Outbreak in the Subcontinent: A data-driven analysis

Human civilization is experiencing a critical situation that presents it...
research
05/05/2020

In Silico Trial to test COVID-19 candidate vaccines: a case study with UISS platform

SARS-CoV-2 is a severe respiratory infection that infects humans. Its ou...

Please sign up or login with your details

Forgot password? Click here to reset